These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria). Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601 [TBL] [Abstract][Full Text] [Related]
23. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis. Parikh ND; Waljee AK; Singal AG Liver Transpl; 2015 Sep; 21(9):1142-52. PubMed ID: 25981135 [TBL] [Abstract][Full Text] [Related]
24. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474 [TBL] [Abstract][Full Text] [Related]
25. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. Kim Y; Stahl CC; Makramalla A; Olowokure OO; Ristagno RL; Dhar VK; Schoech MR; Chadalavada S; Latif T; Kharofa J; Bari K; Shah SA Surgery; 2017 Dec; 162(6):1250-1258. PubMed ID: 29033224 [TBL] [Abstract][Full Text] [Related]
26. Effect of Downstaging and Bridging of Hepatocellular Carcinoma on Survival Following Liver Transplant: A Single Center Experience. Al Sebayel MI; Elsiesy H; Al-Hamoudi W; Alabbad S; ElSheikh Y; Elbeshbeshy H; Salih I; Yousif S; Saleh Y; Eldali A; Abaalkhail FA Exp Clin Transplant; 2017 Mar; 15(Suppl 2):7-11. PubMed ID: 28301992 [TBL] [Abstract][Full Text] [Related]
27. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest. Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680 [TBL] [Abstract][Full Text] [Related]
28. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study. Chagas AL; Mattos AA; Diniz MA; Felga GEG; Boin IFSF; Silva RCMA; Silva RF; Garcia JHP; Lima AS; Coelho JCU; Bittencourt PL; Alves VAF; D'Albuquerque LAC; Carrilho FJ; Ann Hepatol; 2021; 22():100294. PubMed ID: 33276136 [TBL] [Abstract][Full Text] [Related]
30. Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria. Gunsar F Exp Clin Transplant; 2017 Mar; 15(Suppl 2):59-64. PubMed ID: 28302001 [TBL] [Abstract][Full Text] [Related]
31. Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma. Rudnick SR; Russo MW Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):265-275. PubMed ID: 29231769 [TBL] [Abstract][Full Text] [Related]
32. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience. Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821 [TBL] [Abstract][Full Text] [Related]
33. Benefit of downsizing hepatocellular carcinoma in a liver transplant population. Jang JW; You CR; Kim CW; Bae SH; Yoon SK; Yoo YK; Kim DG; Choi JY Aliment Pharmacol Ther; 2010 Feb; 31(3):415-23. PubMed ID: 19821808 [TBL] [Abstract][Full Text] [Related]
34. Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma. Tabrizian P; Holzner ML; Mehta N; Halazun K; Agopian VG; Yao F; Busuttil RW; Roberts J; Emond JC; Samstein B; Brown RS; Najjar M; Chapman WC; Doyle MM; Florman SS; Schwartz ME; Llovet JM JAMA Surg; 2022 Sep; 157(9):779-788. PubMed ID: 35857294 [TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center. Baccarani U; Adani GL; Avellini C; Lorenzin D; Currò G; Beltrami A; Pasqualucci A; Bresadola V; Risaliti A; Viale PL; Beltrami CA; Bresadola F Transplant Proc; 2006 May; 38(4):1111-3. PubMed ID: 16757280 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131 [TBL] [Abstract][Full Text] [Related]
37. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis. Barakat O; Wood RP; Ozaki CF; Ankoma-Sey V; Galati J; Skolkin M; Toombs B; Round M; Moore W; Mieles L Liver Transpl; 2010 Mar; 16(3):289-99. PubMed ID: 20209588 [TBL] [Abstract][Full Text] [Related]
38. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158 [TBL] [Abstract][Full Text] [Related]
39. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454 [TBL] [Abstract][Full Text] [Related]
40. Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. De Luna W; Sze DY; Ahmed A; Ha BY; Ayoub W; Keeffe EB; Cooper A; Esquivel C; Nguyen MH Am J Transplant; 2009 May; 9(5):1158-68. PubMed ID: 19344435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]